REGENT SQUARE GROUP PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: C86006 | DONCASTER, DN1 2DS
Showing results 601-650 of 653
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Choline salicylate | 13 | 195 | £47 | +193.9% ▲ |
| Cocois | 13 | 1,300 | £194 | -5.3% ▼ |
| 13 | 130 | £427 | -57.7% ▼ | |
| 13 | 480 | £1.2K | -14.7% ▼ | |
| Glycopyrronium bromide | 12 | 5,400 | £3.7K | -41.5% ▼ |
| Celiprolol hydrochloride | 12 | 672 | £420 | -9.3% ▼ |
| Bempedoic acid/Ezetimibe | 12 | 336 | £632 | -80.3% ▼ |
| Salmeterol | 12 | 12 | £339 | -50.1% ▼ |
| Midazolam hydrochloride | 12 | 48 | £1.1K | -16.7% ▼ |
| Levofloxacin | 12 | 190 | £225 | +132.8% ▲ |
| Metformin hydrochloride/vildagliptin | 12 | 720 | £407 | -26.6% ▼ |
| Flavoxate hydrochloride | 12 | 672 | £84 | +1.6% vs avg |
| Potassium citrate | 12 | 2,796 | £808 | +41.4% ▲ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 12 | 58.0K | £1.3K | -3.2% ▼ |
| Ready to serve preterm infant formula (0913111) | 12 | 201.6K | £2.0K | +36.7% ▲ |
| Powder amino acid formula (0913131) | 12 | 84.8K | £8.2K | +12.5% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 12 | 352.0K | £8.3K | +25.1% ▲ |
| Epinastine hydrochloride | 12 | 60 | £113 | +180.1% ▲ |
| 12 | 129 | £729 | +39.5% ▲ | |
| 12 | 62 | £442 | +50.7% ▲ | |
| 12 | 24 | £57 | +50.1% ▲ | |
| 12 | 1,300 | £64 | -90.8% ▼ | |
| 12 | 85 | £247 | +28.3% ▲ | |
| 12 | 500 | £281 | -70.4% ▼ | |
| 12 | 800 | £698 | +15.3% ▲ | |
| Nadolol | 11 | 154 | £103 | +8.8% ▲ |
| Lofepramine hydrochloride | 11 | 616 | £263 | -63.2% ▼ |
| Entacapone | 11 | 924 | £193 | -27.8% ▼ |
| Rotigotine | 11 | 308 | £1.1K | -59.2% ▼ |
| Saxagliptin | 11 | 364 | £390 | -67.1% ▼ |
| Water for injection | 11 | 190 | £59 | -67.5% ▼ |
| Vitamin E | 11 | 330 | £11 | +1.2% vs avg |
| RtS 2.4 kcal/ml milkshake lower volume with fibre (0913021) | 11 | 269.5K | £10.0K | +17.3% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 11 | 540 | £31 | -26.8% ▼ |
| Antazoline | 11 | 110 | £35 | +147.6% ▲ |
| Pilocarpine hydrochloride | 11 | 240 | £787 | +7.2% ▲ |
| Salicylic acid | 11 | 143 | £61 | -13.0% ▼ |
| 11 | 11 | £108 | +10.0% ▲ | |
| 11 | 1,100 | £137 | -38.1% ▼ | |
| 11 | 830 | £222 | -59.7% ▼ | |
| 11 | 130 | £402 | +25.5% ▲ | |
| Telmisartan | 10 | 280 | £25 | -82.8% ▼ |
| Ivermectin | 10 | 46 | £561 | +2.5% ▲ |
| Insulin glulisine | 10 | 250 | £1.4K | -53.4% ▼ |
| Ketotifen fumarate | 10 | 120 | £140 | +7.5% ▲ |
| Tafluprost and timolol | 10 | 300 | £145 | -47.9% ▼ |
| Azelaic acid | 10 | 360 | £74 | -58.2% ▼ |
| Ketoconazole | 10 | 420 | £57 | +0.5% vs avg |
| 10 | 100 | £122 | -69.1% ▼ | |
| 10 | 100 | £59 | -73.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.